Site icon pharmaceutical daily

Bayer Focuses on Farmers and Drives Innovation into 2022

Product launches made 2021 a busy year, with game-changing technology on the way

ST. LOUIS–(BUSINESS WIRE)–Harvest is a time for North American farmers to reflect on the past season’s successes and challenges, while looking ahead to what’s next. Bayer – with No. 1 market positions in corn, soybean and cotton acres in the U.S. – is also excited about the future and the next round of cutting-edge technologies for growers in 2022 and beyond.

Among Bayer’s milestones during the 2021 season:

“Earning our farmer-customers’ business every season means bringing them innovative products and additional tools in their toolbox,” said Jackie Applegate, President, North America Crop Science for Bayer. “Challenges like evolving pests and a changing climate, farmers need a steady supply of innovation, and Bayer is focused on delivering.”

Bayer’s plans for continued innovation focus on risk-mitigation strategies for farmers. Short Stature Corn,4 planned for early-to-mid decade in the U.S., will provide a way for farmers to manage against adverse weather while also adding a level of precision that assists in more calculated placement of nutrients mid-season. In addition, later this decade Bayer’s soybean portfolio plans to add the industry’s first 5- and 6-herbicide tolerant stacks, while expanding integrated weed management options. Advancing in Bayer’s crop protection pipeline to Phase 3 this year, is a product that would be the industry’s first new post-emergent broad-acre weed control option in 30 years.

“Now is a great time to help shape the future of agriculture,” said Applegate. “Clearly, our challenges as a planet are many. But the good news is that Bayer is in an outstanding position to keep meeting these dynamic needs today and tomorrow, building a future of health for all and hunger for none.”

1.

SmartStax® PRO corn products will be commercially available for the 2022 growing season.

2.

ThryvOn™ Technology has received full approval for planting in the United States but, as of the date this material was published, is pending approval in certain export markets. Specific plans for commercialization depend upon regulatory approvals and other factors.

3.

ThryvOn™ Technology may help reduce insecticide applications for tarnished plant bugs and thrips species (tobacco thrips (Frankliniella fusca); Western flower thrips (Frankliniella occidentalis); tarnished plant bug (Lygus lineolaris); and the Western Tarnished Plant bug (Lygus Hesperus)). Scouting is critical to determine which and how many insecticide applications are recommended to avoid economic losses greater than the pest management costs (i.e., when economic thresholds are met).

4.

This product is not currently available for commercial sale or commercial planting. Commercialization is dependent on multiple factors, including successful conclusion of the regulatory process. The information presented herein is provided for educational purposes only, and is not and shall not be construed as an offer to sell.

About Bayer:

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

Contacts

Bayer – Kyel Richard, 573-356-0241
kyel.richard@bayer.com

Bayer – Brian Leake, 314-370-3285
brian.leake@bayer.com

Exit mobile version